Core Viewpoint - B2Gold Corp. (BTG) is marked with a Strong Buy rating due to a significant valuation disconnect between current transitional friction and the anticipated free cash flow (FCF) inflection expected in 2026 [1] Group 1 - The upcoming Q4 earnings report is scheduled for release on February 18, 2026 [1]

12 In September 2025, Radian announced it had entered into a definitive agreement to acquire Inigo in a primarily all-cash transaction. The purchase price paid at closing, net of certain adjustments, was $1.67 billion. Inigo's estimated tangible equity at year end 2025 was $1.16 billion, resulting in a net purchase price multiple of approximately 1.4 times tangible equity. The transaction was funded by Radian's available liquidity sources and by using excess capital from its mortgage insurance subsidiary, R ...

FreightTech startup GenLogs announced on February 2, 2026, that it has closed a $60 million Series B funding round. The investment, led by Battery Ventures and including participation from IVP, Cathay Innovation, 9Yards, and existing backers like Venrock, Steel Atlas, HOF Capital, TitletownTech, and Autotech Ventures, brings the company’s total funding to $81 million since its founding in 2023. This latest capital raise aims to expand GenLogs’ AI-powered Truck Intelligence ™ platform, which leverages a n ...

NEW YORK--(BUSINESS WIRE)---- $UI #investigation--Scott+Scott Attorneys at Law LLP ("Scott+Scott†), an international securities and consumer rights litigation firm, is investigating whether the leadership of Ubiquiti Inc. ("Ubiquiti†) (NYSE: UI) breached their fiduciary duties to Ubiquiti and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of Ubiquiti's board of directors or senior management failed to manage Ubiquiti in an acceptable manner, in breach of their fi ...

Group 1 - The article discusses the potential for investors to position themselves in undervalued stocks that are mispriced by the market as of January [1] - Stone Fox Capital, based in Oklahoma, is led by Mark Holder, a CPA with 30 years of investing experience, including 15 years as a portfolio manager [2] - The investing group "Out Fox The Street" provides stock picks, deep research, model portfolios, daily updates, real-time alerts, and community chat for investors [2] Group 2 - The article emphasizes the importance of conducting personal research or consulting a financial advisor before making investment decisions [4] - It highlights that past performance is not indicative of future results and that no specific investment recommendations are provided [5]

We recently published an article titled 10 High Growth Food Stocks To Buy.  JPMorgan raised its price target on Celsius Holdings, Inc (NASDAQ:CELH) to $77 from $68 on January 29 while maintaining an Overweight rating as part of its Q4 earnings preview. The firm sees a favorable setup heading into earnings, with potential upside to both estimates and valuation multiples. JPMorgan expects Celsius to benefit meaningfully in 2026 from its category captaincy role under the expanded PepsiCo partnership, while A ...

Tesla stock (NASDAQ: TSLA) tumbled over 3.5% in the early trading on Monday as the electric carmaker confronts a convergence of structural headwinds. ...

Core Insights - Meta Platforms is making significant investments in AI, which are expected to lead to higher Return on Invested Capital (ROIC) and should not raise concerns regarding the company's substantial capital expenditures [1]. Group 1: Company Overview - Meta Platforms is focused on leveraging AI technology to enhance its financial performance and operational efficiency [1]. Group 2: Investment Perspective - The company's high capital expenditures are viewed positively in the context of long-term value creation and potential returns from AI investments [1].

Warner Bros Discovery is likely to hold a shareholder vote on the $82.7 billion deal to sell its streaming and studio assets to Netflix in March, CNBC reported on Monday. ...

Core Insights - SEQSTER and Praxis Precision Medicines have expanded their partnership to enhance clinical trials, data collection, and real-world evidence generation for Praxis's clinical development programs [1][2][4] Group 1: Partnership and Collaboration - SEQSTER has been integral to Praxis's clinical trial execution, improving trial enrollment efficiency and capturing necessary longitudinal real-world data [2][3] - The partnership focuses on advancing the ENERGY program, which includes the EMPOWER observational study and POWER clinical studies, attracting over 5,000 patients with epilepsy [3][4] Group 2: Company Profiles - Praxis Precision Medicines is a leading biopharmaceutical company specializing in central nervous system (CNS) disorders, utilizing genetic insights to develop therapies for various neurological conditions [5] - SEQSTER is a healthcare technology company that consolidates patient-consented health data into a unified view, supporting research and patient health management with a repository of 150 million patients [6][7]